Fred W. Lyons
Corporate Officer/Principal chez MRIGlobal
Profil
Fred W.
Lyons is a Trustee at MRIGlobal.
He was the Chairman & Co-Chief Executive Officer at OSI Pharmaceuticals, Inc. from 1994 to 1997.
He was also the Chairman & Chief Executive Officer at Marion Merrell Dow, Inc. Additionally, he served as Vice President at Alcon Laboratories, Inc. from 1958 to 1969.
He was a Special Partner at Kansas City Equity Partners LC from 1999 to 2008.
Lyons holds an MBA from Harvard University and an undergraduate degree from the University of Michigan.
Postes actifs de Fred W. Lyons
| Sociétés | Poste | Début |
|---|---|---|
MRIGlobal
 MRIGlobal Miscellaneous Commercial ServicesCommercial Services MRIGlobal operates research and development organizations. The firm's programs include environmental research, health, pharmaceutical product development, agriculture & food safety, and national security, defense & energy. The company was founded in 1944 and headquartered in Kansas City, MO. | Corporate Officer/Principal | - |
Anciens postes connus de Fred W. Lyons
| Sociétés | Poste | Fin |
|---|---|---|
Kansas City Equity Partners LC
 Kansas City Equity Partners LC Investment ManagersFinance KCEP invests across the United States, however the majority of ventures funded are in the Midwest. KCEP invests in growth companies along targeted industries and works in partnership with entrepreneurial management teams to build long-term value. KCEP often leads or co-leads the investment syndicate, and has the ability to assist in syndication of all debt and equity to respond to the financing needs of a growing company. By focusing on three key industries, Communications, Consumer and Natural Resources, KCEP is better able to develop a deeper level of expertise, as well as a base of industry, financial and investor contacts. KCEP invests within range of $2 to $6 million. The firms headquartered in United States which it invests, are valued beginning from $10 to $100 million. | Private Equity Investor | 24/01/2008 |
| OSI PHARMACEUTICALS, INC. | Directeur Général | 01/03/1994 |
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Corporate Officer/Principal | 31/12/1969 |
| Marion Merrell Dow, Inc. | Corporate Officer/Principal | - |
Formation de Fred W. Lyons
| Harvard University | Masters Business Admin |
| University of Michigan | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
| Marion Merrell Dow, Inc. | Health Technology |
Alcon Laboratories, Inc.
Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Health Technology |
MRIGlobal
MRIGlobal Miscellaneous Commercial ServicesCommercial Services MRIGlobal operates research and development organizations. The firm's programs include environmental research, health, pharmaceutical product development, agriculture & food safety, and national security, defense & energy. The company was founded in 1944 and headquartered in Kansas City, MO. | Commercial Services |
Kansas City Equity Partners LC
Kansas City Equity Partners LC Investment ManagersFinance KCEP invests across the United States, however the majority of ventures funded are in the Midwest. KCEP invests in growth companies along targeted industries and works in partnership with entrepreneurial management teams to build long-term value. KCEP often leads or co-leads the investment syndicate, and has the ability to assist in syndication of all debt and equity to respond to the financing needs of a growing company. By focusing on three key industries, Communications, Consumer and Natural Resources, KCEP is better able to develop a deeper level of expertise, as well as a base of industry, financial and investor contacts. KCEP invests within range of $2 to $6 million. The firms headquartered in United States which it invests, are valued beginning from $10 to $100 million. | Finance |
